Plain-English translation of NCT05938478 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study is tracking the health outcomes of pregnant people with atopic dermatitis (eczema) to understand how a medication called affects pregnancy and baby health. Researchers will compare women who used this medication during pregnancy to women with eczema who used other treatments or no treatment at all. By collecting this information, doctors hope to better understand whether the medication is safe to use while pregnant.
Many pregnant people with eczema need effective treatment, but there isn't enough real-world safety data about how certain newer medications affect pregnancy and infant development. This study exists to fill that gap by carefully tracking outcomes and helping doctors make informed recommendations for pregnant patients.
You likely qualify if…
You likely don't qualify if…
Participants will complete interviews about their pregnancy, medical history, and treatment choices. For some participants, their baby will receive a physical exam and developmental screening during the first year of life. Researchers will also collect and review medical records to track pregnancy complications, delivery outcomes, and infant health through age one. The study is observational, meaning participants continue their regular medical care while researchers gather and monitor the data.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States